FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783201393> ?p ?o ?g. }

• W2783201393 endingPage "962" @default.
• W2783201393 startingPage "953" @default.
• W2783201393 abstract "Neisseria meningitidis serogroups A and X are among the leading causes of bacterial meningitis in the African meningitis belt. Glycoconjugate vaccines, consisting of an antigenic carrier protein coupled to the capsular polysaccharide of the bacterial pathogen, are the most effective strategy for prevention of meningococcal disease. However, the distribution of effective glycoconjugate vaccines in this region is limited by the high cost of cultivating pathogens and purification of their capsular polysaccharides. Moreover, chemical approaches to synthesize oligosaccharide antigens have proven challenging. In the current study, we present a chemoenzymatic approach for generating tailored oligosaccharide fractions ready for activation and coupling to the carrier protein. In a first step, the elongation modes of recombinant capsular polymerases from Neisseria meningitidis serogroups A (CsaB) and X (CsxA) were characterized. We observed that CsaB is a distributive enzyme, and CsxA is a processive enzyme. Sequence comparison of these two stealth family proteins revealed a C-terminal extension in CsxA, which conferred processivity because of the existence of a second product-binding site. Deletion of the C-terminal domain converted CsxA into a distributive enzyme, allowing facile control of product length by adjusting the ratio of donor to acceptor sugars. Solid-phase fixation of the engineered capsular polymerases enabled rapid production of capsular polysaccharides with high yield and purity. In summary, the tools developed here provide critical steps toward reducing the cost of conjugate vaccine production, which will increase access in regions with the greatest need. Our work also facilitates efforts to study the relationship between oligosaccharide size and antigenicity. Neisseria meningitidis serogroups A and X are among the leading causes of bacterial meningitis in the African meningitis belt. Glycoconjugate vaccines, consisting of an antigenic carrier protein coupled to the capsular polysaccharide of the bacterial pathogen, are the most effective strategy for prevention of meningococcal disease. However, the distribution of effective glycoconjugate vaccines in this region is limited by the high cost of cultivating pathogens and purification of their capsular polysaccharides. Moreover, chemical approaches to synthesize oligosaccharide antigens have proven challenging. In the current study, we present a chemoenzymatic approach for generating tailored oligosaccharide fractions ready for activation and coupling to the carrier protein. In a first step, the elongation modes of recombinant capsular polymerases from Neisseria meningitidis serogroups A (CsaB) and X (CsxA) were characterized. We observed that CsaB is a distributive enzyme, and CsxA is a processive enzyme. Sequence comparison of these two stealth family proteins revealed a C-terminal extension in CsxA, which conferred processivity because of the existence of a second product-binding site. Deletion of the C-terminal domain converted CsxA into a distributive enzyme, allowing facile control of product length by adjusting the ratio of donor to acceptor sugars. Solid-phase fixation of the engineered capsular polymerases enabled rapid production of capsular polysaccharides with high yield and purity. In summary, the tools developed here provide critical steps toward reducing the cost of conjugate vaccine production, which will increase access in regions with the greatest need. Our work also facilitates efforts to study the relationship between oligosaccharide size and antigenicity." @default.
• W2783201393 created "2018-01-26" @default.
• W2783201393 creator A5025303012 @default.
• W2783201393 creator A5057948124 @default.
• W2783201393 creator A5060218108 @default.
• W2783201393 creator A5079172960 @default.
• W2783201393 creator A5086617572 @default.
• W2783201393 creator A5089900216 @default.
• W2783201393 date "2018-01-01" @default.
• W2783201393 modified "2023-10-01" @default.
• W2783201393 title "Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production" @default.
• W2783201393 cites W1512191701 @default.
• W2783201393 cites W1803102843 @default.
• W2783201393 cites W1963552245 @default.
• W2783201393 cites W1980781560 @default.
• W2783201393 cites W1981494855 @default.
• W2783201393 cites W1982168027 @default.
• W2783201393 cites W2003358759 @default.
• W2783201393 cites W2015776011 @default.
• W2783201393 cites W2030593951 @default.
• W2783201393 cites W2033615217 @default.
• W2783201393 cites W2040546171 @default.
• W2783201393 cites W2050057463 @default.
• W2783201393 cites W2055193239 @default.
• W2783201393 cites W2078693885 @default.
• W2783201393 cites W2085585050 @default.
• W2783201393 cites W2087585684 @default.
• W2783201393 cites W2087885447 @default.
• W2783201393 cites W2091767016 @default.
• W2783201393 cites W2092557521 @default.
• W2783201393 cites W2105664303 @default.
• W2783201393 cites W2108925141 @default.
• W2783201393 cites W2111015751 @default.
• W2783201393 cites W2112765785 @default.
• W2783201393 cites W2117364171 @default.
• W2783201393 cites W2121816463 @default.
• W2783201393 cites W2133858145 @default.
• W2783201393 cites W2143873194 @default.
• W2783201393 cites W2150754166 @default.
• W2783201393 cites W2153881951 @default.
• W2783201393 cites W2162972766 @default.
• W2783201393 cites W2164478392 @default.
• W2783201393 cites W2171341978 @default.
• W2783201393 cites W2175581166 @default.
• W2783201393 cites W2323883449 @default.
• W2783201393 cites W2518529034 @default.
• W2783201393 cites W2551650437 @default.
• W2783201393 cites W2576413724 @default.
• W2783201393 cites W2592211706 @default.
• W2783201393 cites W2610479233 @default.
• W2783201393 cites W2749180455 @default.
• W2783201393 cites W4211036196 @default.
• W2783201393 doi "https://doi.org/10.1074/jbc.ra117.000488" @default.
• W2783201393 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5777266" @default.
• W2783201393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29187601" @default.
• W2783201393 hasPublicationYear "2018" @default.
• W2783201393 type Work @default.
• W2783201393 sameAs 2783201393 @default.
• W2783201393 citedByCount "27" @default.
• W2783201393 countsByYear W27832013932018 @default.
• W2783201393 countsByYear W27832013932019 @default.
• W2783201393 countsByYear W27832013932020 @default.
• W2783201393 countsByYear W27832013932021 @default.
• W2783201393 countsByYear W27832013932022 @default.
• W2783201393 countsByYear W27832013932023 @default.
• W2783201393 crossrefType "journal-article" @default.
• W2783201393 hasAuthorship W2783201393A5025303012 @default.
• W2783201393 hasAuthorship W2783201393A5057948124 @default.
• W2783201393 hasAuthorship W2783201393A5060218108 @default.
• W2783201393 hasAuthorship W2783201393A5079172960 @default.
• W2783201393 hasAuthorship W2783201393A5086617572 @default.
• W2783201393 hasAuthorship W2783201393A5089900216 @default.
• W2783201393 hasBestOaLocation W27832013931 @default.
• W2783201393 hasConcept C100817775 @default.
• W2783201393 hasConcept C104317684 @default.
• W2783201393 hasConcept C13426554 @default.
• W2783201393 hasConcept C179069550 @default.
• W2783201393 hasConcept C185592680 @default.
• W2783201393 hasConcept C2777313579 @default.
• W2783201393 hasConcept C2777726330 @default.
• W2783201393 hasConcept C2777954195 @default.
• W2783201393 hasConcept C2778458888 @default.
• W2783201393 hasConcept C2779583294 @default.
• W2783201393 hasConcept C2781253189 @default.
• W2783201393 hasConcept C501593827 @default.
• W2783201393 hasConcept C523546767 @default.
• W2783201393 hasConcept C54355233 @default.
• W2783201393 hasConcept C55493867 @default.
• W2783201393 hasConcept C60987743 @default.
• W2783201393 hasConcept C86803240 @default.
• W2783201393 hasConcept C89423630 @default.
• W2783201393 hasConceptScore W2783201393C100817775 @default.
• W2783201393 hasConceptScore W2783201393C104317684 @default.
• W2783201393 hasConceptScore W2783201393C13426554 @default.
• W2783201393 hasConceptScore W2783201393C179069550 @default.
• W2783201393 hasConceptScore W2783201393C185592680 @default.
• W2783201393 hasConceptScore W2783201393C2777313579 @default.
• W2783201393 hasConceptScore W2783201393C2777726330 @default.

• next